EBI-1051

N/A

Report date: 2022/06/01 14:23:45
NME

Base Information

Drug NameEBI-1051
Drug Alias NameEBI-1051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co LtdEternity Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesEternity Bioscience IncShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A